The acceptable threshold for glucocorticoid use for lupus maintenance therapy should be 5 mg per day prednisone equivalent or less, according to the updated 2023 EULAR recommendations for the ...
Please provide your email address to receive an email when new articles are posted on . EULAR recommendations on pharmacological PsA management cover all available drugs in a “practical and ...
The European Alliance of Associations for Rheumatology (EULAR) 2024 European Congress of Rheumatology Annual Meeting is about to take place in Vienna, Austria. From June 12-15, some of the world's ...
Over the period 2018 - 2023, EULAR, the leading organization in RMDs, has grown substantially and has been professionalized in every aspect. For example, EULAR has increased its impact on RMDs through ...
STOCKHOLM, May 28, 2025 /PRNewswire/ -- Sobi® (STO: SOBI) will present new clinical data and research outcomes at the annual European Congress of Rheumatology (EULAR 2025) in Barcelona from the 11-14 ...
Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced the ...
Biotech firm shares phase 2 findings on novel osteoarthritis treatmen Levicept has presented new data from its phase 2 trial of LEVI-04 at the European Congress of Rheumatology (EULAR 2025). The first ...
Many rheumatologic conditions such as rheumatoid arthritis and lupus often strike women during their reproductive years, with drugs being the primary therapies. Experts assembled by EULAR determined ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback